UMass Chan Joins Major Collaborative Effort to Advance Type 1 Diabetes Research

A new JDRF Center of Excellence brings together researchers from UMass Chan Medical School, Harvard, and Jackson Laboratory to study how Type 1 diabetes develops—work that could eventually lead to better treatments.

cure researchbeta cellsadvancements

Key takeaways

UMass Chan Medical School has joined a JDRF-supported Center of Excellence focused on understanding Type 1 diabetes at the cellular level
The collaborative team includes researchers from Harvard, Jackson Laboratory, and UMass Chan working together on stem cell research
Scientists are using stem cells and specialized humanized mouse models to study how Type 1 diabetes develops
Understanding diabetes pathogenesis—how the disease actually works—is considered essential groundwork for developing new treatments

A Multi-Institution Research Partnership Takes Shape

UMass Chan Medical School has become part of a significant collaborative research effort supported by JDRF. The center brings together expertise from multiple institutions, including Harvard University, Jackson Laboratory, and the UMass team, to tackle fundamental questions about Type 1 diabetes.

The partnership represents a convergence of long-standing research interests. Researchers at these institutions have been pursuing answers to diabetes for decades, and this formal collaboration allows them to combine their strengths and resources.

How Stem Cells and Mouse Models Advance Understanding

At the heart of this research effort is the use of stem cells paired with specialized humanized mouse models. These tools allow scientists to study what happens in the body during Type 1 diabetes development in ways that wouldn't be possible with traditional research methods.

The humanized mouse models were developed by researchers at Jackson Laboratory and UMass Chan. These models are designed to more closely mirror human biology, making findings from animal studies more likely to translate to human disease.

Understanding Disease Development as a Path Forward

A central goal of the Center of Excellence is to understand the pathogenesis of Type 1 diabetes—essentially, how and why the disease develops. This foundational knowledge is considered crucial for identifying new treatment approaches.

Researchers believe that by truly understanding the mechanisms underlying Type 1 diabetes, they will be better positioned to develop interventions that could change the course of the disease. This research represents a long-term commitment to advancing the field beyond current treatment options.

Evidence label

Origin: YouTube / UMass Chan Medical School (Video report). Evidence: Video report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.